HB 1809STATE · New HampshireIntroduced

establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

Latest action: Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/07/2026; SJ 11

Voted: 5/5/2026Source

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

4/23/2026Committee Report: Inexpedient to Legislate, 05/07/2026, Vote 4-0, CC; SC 17
4/1/2026Hearing: 04/08/2026, Room 100, SH, 09:45 am; SC 13
3/30/2026Introduced 03/26/2026 and Referred to Health and Human Services; SJ 7
3/26/2026Inexpedient to Legislate: MF DV 127-222 03/26/2026 HJ 9
3/26/2026Amendment # 2026-1201h (NT): AA DV 248-101 03/26/2026 HJ 9
3/26/2026Ought to Pass with Amendment 2026-1201h: MA VV 03/26/2026 HJ 9
3/19/2026Majority Committee Report: Inexpedient to Legislate 03/17/2026 (Vote 13-11; RC)
3/19/2026Minority Committee Report: Ought to Pass with Amendment # 2026-1201h (NT)
3/13/2026Executive Session: 03/17/2026 10:00 am GP 230
3/9/2026Division III Work Session: 03/13/2026 09:00 am GP 234